4.6 Review

Prospects for the Use of ATR Inhibitors to Treat Cancer

期刊

PHARMACEUTICALS
卷 3, 期 5, 页码 1311-1334

出版社

MDPI
DOI: 10.3390/ph3051311

关键词

Replication checkpoint; ATR; ATM; chemotherapy; Chk1

向作者/读者索取更多资源

ATR is an apical kinase in one of the DNA-damage induced checkpoint pathways. Despite the development of inhibitors of kinases structurally related to ATR, as well as inhibitors of the ATR substrate Chk1, no ATR inhibitors have yet been developed. Here we review the effects of ATR downregulation in cancer cells and discuss the potential for development of ATR inhibitors for clinical use.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据